Description
Settlement schedule and procedures for the takeover offer of PHARMAIDS PHARMACEUTICALS LIMITED through BSE acquisition window from August 4-18, 2025.
Summary
BSE has announced the settlement schedule for the takeover offer of PHARMAIDS PHARMACEUTICALS LIMITED through the acquisition window mechanism. The offer will run from August 4-18, 2025, with settlement number 2025067 and final settlement on September 1, 2025.
Key Points
- Takeover offer period: August 4-18, 2025
- Settlement number: 2025067
- Obligation download: August 29, 2025
- Final settlement date: September 1, 2025
- Demat shares must be delivered through Early Pay-in mechanism only
- Available through both CDSL and NSDL depositories
Regulatory Changes
No new regulatory changes introduced. This follows existing revised guidelines for share acquisition through stock exchange as per Notice No.20200528-32 dated May 28, 2020.
Compliance Requirements
- Members/Custodians must use Market Type “(Takeover)” and settlement No.2025067 in depository systems
- Early pay-in of securities must be completed sufficiently in advance before BSE OTB bidding window closure
- Securities will be automatically earmarked/blocked in client accounts
- No EPN file upload required
- Members must refer to MBRSTD_OTB_CM file for client-wise stamp duty charges
Important Dates
- August 4, 2025: Bid start date
- August 18, 2025: Bid end date
- August 29, 2025: Obligation download
- September 1, 2025: Settlement date
Impact Assessment
This is a company-specific settlement schedule affecting only PHARMAIDS PHARMACEUTICALS LIMITED shareholders and market participants involved in the takeover process. The defined timeline provides clarity for members and custodians to prepare for the acquisition window procedures.
Impact Justification
Company-specific takeover settlement schedule with defined timelines for market participants